In recent decades, bioactive peptides have attracted increasing interest as health promoting functional foods. A variety of naturally formed bioactive peptides have been found in fermented dairy products such as yogurt, sour milk, and cheese. Initially these peptides are inactive within the sequence of the parent protein molecule and can be generated by gastrointestinal digestion of milk, fermentation of milk with proteolytic starter cultures, and/or hydrolysis by proteolytic enzymes. Milk derived peptides exert a number of health beneficial activities, even upon oral administration. Bioactive peptides have a great impact on major body systems including the digestive, nervous, endocrine, cardiovascular, diabetes type II, obesity, and immune systems. Antimicrobial peptides are also an important ingredient of innate immunity, especially at mucosal surfaces such as lungs and small intestine that are constantly exposed to a range of potential pathogens. Therefore, it plays an important role in boosting natural immune protection by reducing the risk of chronic diseases. Bioactive peptides are considered as potent drugs with well-defined pharmacological residues and also used to formulate health-enhancing nutraceuticals.

The growing demand for sustainable animal production is compelling researchers to explore the potential approaches to reduce emissions of greenhouse gases from livestock that are mainly produced by enteric fermentation. Some potential solutions, for instance, the use of chemical inhibitors to reduce methanogenesis, are not feasible in routine use due to their toxicity to ruminants, inhibition of efficient rumen function or other transitory effects. Strategies, such as use of plant secondary metabolites and dietary manipulations have emerged to reduce the methane emission, but these still require extensive research before these can be recommended and deployed in the livestock industry sector. Furthermore, immunization vaccines for methanogens and phages are also under investigation for mitigation of enteric methanogenesis. The increasing knowledge of methanogenic diversity in rumen, DNA sequencing technologies and bioinformatics have paved the way for chemogenomic strategies by targeting methane producers. Chemogenomics will help in finding target enzymes and proteins, which will further assist in the screening of natural as well chemical inhibitors. The construction of a methanogenic gene catalogue through these approaches is an attainable objective. This will lead to understand the microbiome function, its relation with the host and feeds, and therefore, will form the basis of practically viable and eco-friendly methane mitigation approaches, while improving the ruminant productivity.

Climate change and the urgent need to reduce greenhouse gas (GHG) emission from agriculture has resulted in significant pressure on the livestock industry for advanced practices that are environmentally more sustainable. Livestock is responsible for more than 15% of anthropogenic methane (CH₄) emission via enteric fermentation and improved strategies for mitigating enteric CH₄ production therefore represents a promising target to reduce the overall GHG contribution from agriculture. Ruminal CH₄ is produced by methanogenic archaea, combining CO₂ and hydrogen (H₂). Removal of H₂ is essential, as its accumulation inhibits many biological functions that are essential for maintaining a healthy rumen ecosystem. Although several other pathways occur in the rumen, including reductive acetogenesis, propionogenesis, nitrate, and sulfate reduction, methanogenesis seems to be the dominant pathway for H₂ removal. Global warming is not the only problem associated with the release of CH₄ from ruminants, but the released GHG also represent valuable metabolic energy that is lost to the animal and that needs to be replenished via its food. Therefore, reduction of enteric CH₄ emissions will benefit not only the environment but also be an important step toward the efficient production of high-quality animal-based protein. In recent decades, several approaches, relying on a diverse set of biological and chemical compounds, have been tested for their ability to inhibit rumen methanogenesis reliably and without negative effects for the ruminant animal. Although many of these strategies initially appeared to be promising, they turned out to be less sustainable on the industrial scale and when implemented over an extended period. The development of a long-term solution most likely has been hindered by our still incomplete understanding of microbial processes that are responsible for maintaining and dictating rumen function. Since manipulation of the overall structure of the rumen microbiome is still a significant challenge targeting key intermediates of rumen methanogenesis, such as H₂, and population that are responsible for maintaining the H₂ equilibrium in the rumen could be a more immediate approach. Addition of microorganisms capable of non-methanogenic H₂ sequestration or of reducing equivalents are potential avenues to divert molecular H₂ from methanogenesis and therefore for abate enteric CH₄. However, in order to achieve the best outcome, a detailed understanding of rumen microbiology is needed. Here we discuss some of the problems and benefits associated with alternate pathways, such as reductive acetogenesis, propionogenesis, and sulfate and nitrate reduction, which would allow us to bypass H₂ production and accumulation in the rumen.